Peripheral Neuropathy Pathophysiology

Understanding the mechanisms behind peripheral nerve damage is essential for any clinician, as it directly informs diagnosis, management, and prognosis. Peripheral neuropathy is not a single disease but a final common pathway for various insults, each with distinct pathophysiological fingerprints that manifest in predictable clinical and electrodiagnostic patterns. By classifying the type and site of injury, you can move from a list of symptoms to a targeted differential diagnosis.

Foundations of Nerve Structure and Injury Patterns

A peripheral nerve is essentially a biological cable containing axons, which are the long projections of neurons, wrapped in insulating myelin sheaths produced by Schwann cells. Injury can target the axon itself, its myelin coating, or the supportive vasculature. The two primary pathophysiological categories are axonal neuropathy and demyelinating neuropathy. In axonal neuropathy, the primary problem is degeneration of the axon cylinder itself, often starting at the most distant point (the axon terminal) and moving backward—a process called length-dependent or "dying-back" neuropathy. In contrast, demyelinating neuropathy involves damage to the myelin sheath, which disrupts the rapid, saltatory conduction of nerve impulses. Most neuropathies show a mixture of both processes, but identifying the predominant pattern is the first critical step.

Axonal vs. Demyelinating Neuropathy: Clinical and Electrodiagnostic Hallmarks

Distinguishing between these patterns hinges on understanding their corresponding nerve conduction study (NCS) findings. Consider a patient with gradual onset of symmetrical foot numbness and burning pain. An NCS in a primary axonal process typically shows reduced amplitude of the sensory and motor action potentials. Amplitude correlates with the number of functioning axons. Conduction velocity, however, remains relatively normal or only mildly slowed, as the surviving, well-myelinated axons conduct electricity normally.

Now, contrast this with a demyelinating neuropathy. Here, the myelin damage causes severe slowing of conduction velocity or conduction block, where the signal fails to propagate past a damaged segment. Amplitudes may be preserved early on, as the axons are initially intact. For example, a conduction velocity below 75% of the lower limit of normal strongly suggests demyelination. Recognizing this pattern is crucial because it narrows the etiology to a short list that includes immune-mediated conditions like Guillain-Barré syndrome or chronic inflammatory demyelinating polyneuropathy (CIDP), which are treatable.

Common Neuropathic Syndromes and Their Mechanisms

Diabetic Polyneuropathy: The Length-Dependent Pattern

The most common neuropathy worldwide, diabetic polyneuropathy, is a premier example of a metabolic axonal injury. Chronic hyperglycemia leads to a cascade of events: increased polyol pathway flux, advanced glycation end-products, and oxidative stress. These processes damage the vasa nervorum (small blood vessels supplying nerves) and directly injure neuronal mitochondria. The result is a length-dependent pattern, where the longest axons—those to the feet—degenerate first. Patients present with the classic "stocking-glove" distribution of sensory loss, pain, and later, weakness. Autonomic fibers are also affected, leading to symptoms like gastroparesis and orthostatic hypotension.

Carpal Tunnel Syndrome: Focal Demyelination from Entrapment

Carpal tunnel syndrome is a model of mononeuropathy caused by localized compression. The median nerve becomes entrapped as it passes through the rigid carpal tunnel in the wrist. The chronic pressure causes focal demyelination at the site of compression. On NCS, this manifests as slowed conduction velocity specifically across the wrist segment, often with a prolonged distal latency. Prolonged severe compression can eventually lead to secondary axonal loss. This illustrates how a localized mechanical problem creates a very specific electrodiagnostic signature.

Wallerian Degeneration: The Aftermath of Transection

When an axon is completely severed—whether by trauma, infarction, or severe compression—a structured degenerative process called Wallerian degeneration occurs in the distal segment. Within 24-36 hours, the axon and myelin sheath break down into fragments, which are then cleared by Schwann cells and macrophages. Crucially, the nerve cell body also undergoes reactive changes, which can affect its ability to regenerate. This process is the final common pathway for acute axonal interruption and explains why recovery after a clean nerve cut is slow and often incomplete, dependent on the rate of axonal regrowth (about 1 mm per day).

Mononeuropathy Multiplex: The Vascular Signature

When multiple individual nerves are affected in an asymmetric, stepwise fashion, you are dealing with mononeuropathy multiplex. The classic pathophysiology is vasculitis, an inflammation of the blood vessels. The inflammatory process occludes the vasa nervorum, causing acute infarction of a nerve fascicle. A patient might present with sudden foot drop (peroneal nerve involvement) and, weeks later, develop wrist drop (radial nerve involvement). This pattern is a medical emergency, as it points to underlying systemic diseases like polyarteritis nodosa or rheumatoid vasculitis requiring urgent immunosuppressive therapy.

Charcot-Marie-Tooth Disease: Hereditary Demyelination and Axonal Variants

Charcot-Marie-Tooth (CMT) disease represents the most common hereditary neuropathy. It is genetically heterogeneous, but most types are caused by mutations affecting proteins essential for myelin structure or axonal transport. CMT1, the most frequent subtype, is a demyelinating form with uniformly slow conduction velocities on NCS. CMT2 is an axonal form. Both typically present in adolescence with distal weakness, foot deformities (pes cavus), and a length-dependent sensory loss. Understanding its hereditary nature shifts management goals from cure to genetic counseling, rehabilitation, and prevention of complications.

Common Pitfalls

1. Misinterpreting "Slowing" on NCS: Concluding that any slowed conduction velocity indicates demyelination is a trap. Mild, uniform slowing is often seen in axonal neuropathies due to the loss of the largest, fastest-conducting fibers. The key is to look for non-uniform, very severe slowing or conduction block to confirm primary demyelination.
2. Overlooking the Asymmetric Pattern: Dismissing an asymmetric neuropathy as a simple radiculopathy or entrapment can cause you to miss mononeuropathy multiplex. Always ask, "Could this be more than one nerve?" and consider vasculitis, especially if the onset is acute or stepwise.
3. Focusing Only on Sugar in Diabetic Neuropathy: While hyperglycemia is the primary driver, diagnosing diabetic polyneuropathy should prompt a comprehensive assessment. You must also evaluate for and manage cardiovascular risk factors, as neuropathy significantly increases the risk of foot ulcers and amputations. The pitfall is treating the glucose while ignoring the foot.
4. Confusing Hereditary with Acquired: Attributing the slowly progressive, symmetric symptoms of CMT to an acquired cause like CIDP can lead to unnecessary and potentially harmful treatments like long-term immunosuppression. A thorough family history and examination for pes cavus and hammer toes are simple, critical steps to avoid this error.

Summary

• Peripheral neuropathies are classified by the primary site of injury: the axon (axonal neuropathy) or its myelin sheath (demyelinating neuropathy), each with distinctive nerve conduction study findings.
• Diabetic polyneuropathy exemplifies a metabolic, length-dependent axonal injury, while carpal tunnel syndrome demonstrates focal demyelination from compression.
• Acute nerve transection triggers Wallerian degeneration in the distal segment, a process central to understanding trauma-related nerve recovery.
• Mononeuropathy multiplex, an asymmetric pattern involving multiple named nerves, is a red flag for vasculitis and nerve infarction.
• Charcot-Marie-Tooth disease is a common hereditary neuropathy with both demyelinating (CMT1) and axonal (CMT2) forms, highlighting the importance of family history in diagnosis.